Investors Chronicle

We start with FTSE 250 retailer Pets at Home (PETS), whose veterinary arm is now making more than the retail business. Mark Robinson unpacks why this may be, the outlook for the year ahead and the valuation case.Our cover feature on 25 years of volatility is next. Julian Hofmann shares a quick recap of the more serious issues investors have dealt with over this period, the lessons learnt and more. Last up, BT (BT). The business's revenue declined year-on-year, but both Ebitda and normalised free cash flow were on the rise. Dan Jones and Mark Robinson unpack what's been going on at the company. Timestamps1:25 Pets at Home14:31 25 years of volatility23:14 BTMore on these topics Pets at Home boosted by higher-margin vet servicesInvesting lessons from the past 25 yearsBT's rationalisation boosts cash flows Hosted on Acast. See acast.com/privacy for more information.

Diploma's latest results proved that investors' confidence in the company is justified. Valeria Martinez joins Dan Jones to unpack the case for the specialist manufacturer, and whether its valuation is becoming stretched. Alex Newman, author of this week's Big Read on global tracker funds, discusses the contradictions that exist in the popular products and what investors can do to overcome them.We wrap up with Alex Hamer on why it might be the end of the road for the cobalt bull run, and China's role in this shift.Timestamps1:28 Diploma10:49 Global stock market trackers25:58 CobaltMore on these topics:Diploma hits all-time high after raising guidanceGlobal trackers are broken – here's how investors can fix themIs it finally time for cobalt to make a comeback? Hosted on Acast. See acast.com/privacy for more information.

We start with Experian's (EXPN) latest results. Host Dan Jones and Julian Hofmann unpack what went right for the business, how it could fare in the event of a US slowdown, and whether investors should get involved. Next up is Imperial Brands (IMB). Chris Akers shares what led to the big share price reaction, how it compares with other competitors in the tobacco industry and what the main attraction is for investors.Last up, Val Cipriani discusses her personal finance feature on investing to travel the world. Listen to find out everything you need to know, from what to do with your home to what kind of portfolio you should build.Timestamps1:28 Experian13:16 Imperial Brands22:33 Investing to travel the world Hosted on Acast. See acast.com/privacy for more information.

The period since the last episode of Lee and the IC has been eventful to say the least, and the pair begin by unpacking Donald Trump's tariffs, the subsequent market sell-off, and how it compares to similar eras in market history. The episode follows in typical fashion, and Lord Lee updates listeners on changes he has made to his portfolio in the period following “liberation day”, including Treatt (TET), and reveals why he believes PZ Cussons (PZC ) is a severely underrated stock.To wrap up, Alex queries Lord Lee on how he may use his M&G dividend, and Lord Lee shares why he has been involved in the stock market for over half a century. Timestamps 1:12 Liberation Day reaction3:33 Lord Lee's opinion of the turn the world is taking5:41 Did Lord Lee expect a climbdown6:51 April's selloff compared to others in history 9:49 Market rebounds to a downturn11:26 UK and US trade deal 14:04 Lord Lee's portfolio during the tariff-induced downturn17:29 Lord Lee's view on holding cash19:09 Treatt22:12 Christie Group 25:44 Workspace29:13 Vianet31:03 PZ Cussons 34:12 Dividend season35:15 Investing for over half a century Hosted on Acast. See acast.com/privacy for more information.

We begin with Arthur Sants and Dan Jones discussing the Apple antitrust issue, the iPhone manufacturer's role in Alphabet's share price fall and Google's place in the search engine world.Michael Fahy, author of this week's Big Read on the future of aviation, up next. He explains some of the developments in the industry, the top players, and what companies may be under threat by the arrival of more modern aviation and fuel sources. Valeria Martinez then covers Mobico's school bus fleet sale. The deal has been in the making for a while and aimed to reduce the company's debt, but the agreement has since led to a significant share price drop. Valeria lays out its current debt situation, why investors are concerned and more. Timestamps 1:17 Apple & Alphabet20:50 The future of aviation34:38 Mobico Hosted on Acast. See acast.com/privacy for more information.

Dave Baxter returns with another IC Interviews, and he sits down with one of the rising stars of fund management, Jasmine Yeo of Ruffer Investment Company, the FTSE 250 trust that aims to deliver positive returns for investors throughout all market situations. Listen to find out how the portfolio is behaving in the wake of Donald Trump's swathe of tariffs, which diversifiers the Forbes 30 Under 30 fund manager is backing, the macro threats the team are positioning for, and more. Timestamps 1:09 How the portfolio has held up 5:10 When it would be sensible to add risk7:09 US exceptionalism 11:53 Bonds 15:45 Reliable protectors17:12 Gold 20:18 Other diversifiers 21:40 Main macro threats and opportunities 24:30 Growth and equity exposurer Hosted on Acast. See acast.com/privacy for more information.

Recent results from Associated British Foods (ABF) highlighted that both its food and retail arms are facing some bumps in the road – think falling sugar prices and tariffs. Mike Fahy, Julian Hofmann and Alex Newman weigh in on everything going on and what investors need to know.Gold next. Its price reached an all-time high this month, and Alex Hamer looks at the drivers behind this boom, where it could fit in a portfolio today, and sheds some light on investment options. Lastly, Jemma Slingo unpacks results from Keystone Law (KEYS). Jemma and Dan discuss why investors were pleased and how changes to its offices aid its balance sheet. Timestamps 1:24 ABF15:46 Gold 29:49 Keystone Law Hosted on Acast. See acast.com/privacy for more information.

In another packed episode, host Dan Jones is joined by Christopher Akers to look at half-year results from car testing company AB Dynamics (ABDP). Can it continue to perform well at a time when the automotive industry is yet again facing a string of pressures, including those dreaded tariffs?Next up is a look at this week's Big Read on ‘survivor shares'. James Norrington introduces the thinking behind the piece and discusses the metrics you can use to find companies that will prosper in an uncertain world. The team then turn to preference shares. While loved by income seekers because of their impressive yields, they may not be long for this world given Aviva's (AV.) successful attempt to cancel some of its prefs this month. Jemma Slingo discusses the implications and whether investors are being too hasty in voting for the cancellation of these shares.1:21 AB Dynamics10:35 Survivor Shares22:13 Preference shares Hosted on Acast. See acast.com/privacy for more information.

As a wealth preservation fund, Personal Assets aims to generate returns above inflation using a long-term approach. But with uncertainty rife thanks to tariffs, the fund is facing a very “interesting” time.In our latest IC Interviews episode, Dave Baxter and Charlotte discuss the talk of the town – tariffs. Listen to the episode to hear the pair unpack the fund's behaviour after the sell-off, why the managers are backing gold, why Charlotte doesn't believe weight-loss drugs are a threat to alcohol stocks, and more. This episode was recorded on 14 April.Timestamps 00:59 How the fund is behaving after the sell-off4:00 Impact of tariffs on stock markets 8:35 Stock markets the fund is favouring12:06 US Treasuries15:44 Sectors to benefit from structural inflation18:31 Gold 20:51 Food and drink stocks 22:49 Weight-loss drugs and alcohol consumption26:27 Markets aside from the US 27:28 The aim of the fund Hosted on Acast. See acast.com/privacy for more information.

We begin with results from electronics manufacturer, TT Electronics (TTG). Michael Fahy and Arthur Sants explain how its North American and European divisions have been performing, and how the senior leadership is changing.Tariffs again, but from a different angle. Arthur Sants, our US correspondent, unpacks how tech stocks Apple (AAPL) and Nvidia (NVDA) are faring, what could happen next and which businesses are best set to prosper. Last up, Mark Robinson covers motor finance and lender S&U's (SUS) results. It faces significant uncertainty due to regulatory issues and a Supreme Court ruling taking place in a few months. Mark and Dan explore what it means for the business and its shareholders.Timestamps 1:30 TT Electronics10:12 Tariffs and trade28:21 S&U Hosted on Acast. See acast.com/privacy for more information.

As tariffs continue to send markets into a frenzy, the panel gives listeners a rundown of how we got here, what's happening now and what lies ahead for untouched industries such as pharmaceuticals. Val Cipriani joins to discuss this week's cover feature on the investing world beyond listed stocks. Val and Dan share how investors can get exposed to unlisted shares, how to find out what they're worth and other tips to find out if you can trust valuations.It's then on to Staffline's (STAF) results. Valeria Martinez reveals why it held up better than its recruiting peers and what its recent PeoplePlus disposal means for the business in the future.Timestamps 1:53 Market frenzy18:13 Unlisted stocks28:27 StafflineClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

The panel unpack details of the swathe of tariffs announced by US President Donald Trump. They discuss what was announced, their curious calculations, the implications on nations and stocks, and what retaliations could occur.Dave Baxter joins to discuss global equity funds, the topic of this week's Big Read. Dave and Dan unpack the thinking behind the piece, some of the companies that crop up in the funds mentioned, including the most popular of the Magnificent Seven and more. Lastly, Jemma Slingo covers the latest on Aviva (AV.), which is attempting to cancel its preference shares. It argues they are an ‘inefficient form of funding', but investors are not too happy with the move. Timestamps1:41 Tariffs21:15 Global equity funds28:15 Aviva Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Dan Jones is joined by Natasha Voase to discuss Bellway's (BWY) results, and what they reveal about the state of the property market. The pair also unpack the future of housebuilding in light of the Spring Statement and what it means for Vistry (VTY) and Barratt Redrow (BTRW).Val Cipriani joins to carry on the Spring Statement conversation, but changing course toward Isas and the various takes experts, investors and providers will have on changes to allowances.Lastly, we're back to company results with Fevertree (FEVR). Mark Robinson explores the wider trends in the beverages sector and the company's deal with brewer Molson Coors.Timestamps1:27 Housebuilders11:12 Isas21:32 FevertreeClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

The Blue Whale Growth fund concentrates on large cap companies across global stock markets. US tech has dominated global indices, investors' minds and until recently, the fund. Dave Baxter talks to manager Stephen Yiu about his updated thoughts on the Magnificent Seven, Donald Trump's impact on the AI play, overlooked sectors and more.This episode was recorded on 24 February.Timestamps00:29 DeepSeek 2:13 Identifying AI winners 5:36 Exiting Microsoft and US tech9:38 Turnover in the fund13:03 Evolution of the fund16:55 Valuations 20:10 European and Asian companies21:54 Trump and the trade war23:33 Areas to keep an eye on27:30 Compelling themes in the fund beyond AI32:09 Overlooked companies34:24 Danaher Hosted on Acast. See acast.com/privacy for more information.

Dan Jones is joined by Alex Newman and Julian Hofmann to discuss the shift away from US shares towards Europe and even the UK – and the implications for investors.Next up, Alex Newman breaks down his Big Read this week on how the ultra-rich invest and what more humble investors can learn from their investing practices.Lastly we turn our attention to UK company reporting and specifically Close Brothers (CBG), whose results this weekprompted a sell-off, with the shadow of motor finance rulings lingering over the company.1:29: The great rotation16:50: The Big Read: Ultra-rich Investors23:51: Close Brothers Hosted on Acast. See acast.com/privacy for more information.

Mark Robinson sits in for Dan Jones this week and is joined by Michael Fahy to discuss building supplier stocks. The sector has had a rough few years with rising inflation and interest rates, and declining demand. Michael explores where the industry goes next.Alex Newman joins to unpack everything going on with FTSE 250 listed shipbroker Clarkson (CKN) whose share price dropped after it released results.Julian Hofmann covers the news of Germany's rearmament. The country faces significant challenges to fund and implement its colossal plan, but stocks are already reaping the benefits.Last up, Valeria Martinez discusses digital revenues in publishing, specifically focusing on Reach (RCH). Mark and Valeria unpack how its new business plan could impact growth.Timestamps5:18 Building suppliers 15:12 Clarkson18:51 Germany's rearmament26:10 Reach Hosted on Acast. See acast.com/privacy for more information.

Anna Bielby took the helm at Vp in September 2023, a year after John took his own stake in the business. In this episode, Bielby, Lord Lee and IC associate editor Alex Newman discuss the equipment leasing group's history, business model, threats and opportunities.As always, Alex and John wrap up with an update on Lord Lee's portfolio, plus his take on defence stocks. Timestamps 0:59 Introduction3:57 Lord Lee's history with the company5:17 Business model & threats6:58 Hinkley Point8:03 Rail demand 11:11 How it fits in Lord Lee's portfolio12:37 Questions from Lord Lee15:33 Current trading outlook17:49 Impact of tariffs18:37 Dividend22:38 2022 sale saga25:24 Concerns over weak valuations28:24 Financials34:39 Changes to Lord Lee's portfolio36:24 Defence Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

We begin with Aberdeen's (ADBN) results, which pleased the market and sent shares up considerably. Julian Hofmann dives into the recent changes at the company and how they will impact investors. Jemma Slingo touches on another asset manager, Schroders (SDR) which also put out results.It's then onto this week's Big Read on the future of mining. Commodities expert and author of the piece Alex Hamer lays out what's shifting the gears in the industry, and how miners will adapt. Listen to hear about permitting and copper mining operations in the US, gold and rare earths. Following the announcement the German government will up its defence spending, Julian Hoffman and Dave Baxter discuss the latest in the defence industry and the ETFs that offer investors a chance to take advantage.Note: The show contains a brief, erroneous mention to Premier African Minerals (PREM). The correct company is Pan African Resources (PAM).Timestamps 1:48 aberdeen8:11 Schroders13:25 Mining28:01 DefenceClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Nick Train is the first to admit that his investors haven't seen the returns they're used to recently. But despite some calls that haven't quite worked out, in this interview, he points out the areas that should make up for this in the future.Listen to Dave Baxter and the fund manager discuss holdings in the fund such as Diageo (DGE) – which he's bullish over despite falling alcohol consumption and the threat of weight loss drugs – and companies tapping into digital trends, such as Relx (RELX).The pair also cover moving away from dividends, the state of UK asset managers, activism in the investment trust space and more.This episode was recorded on 24 February.Timestamps00:51 What could end the underperformance 3:50 Stronger and weaker points of the portfolio and Relx 6:08 How much of the portfolio targets digital trends 8:05 Performance issues 12:39 Diageo20:32 Unilever23:46 Consumer exposure26:20 UK market woes29:42 Rightmove 31:56 Schroders and UK asset managers33:33 Investment trusts36:02 Clarkson and Intertek Hosted on Acast. See acast.com/privacy for more information.

Market darling Rolls Royce (RR) is going from strength to strength. After a return to dividends topped with a lucrative buyback, shares were up 20 per cent on the day of recording. James Norrington, author of this Rolls-Royce Deep Dive, unpacks the prospects for the business and everything investors need to know. Smith & Nephew (SN), a medical equipment manufacturer, continues to improve operating performance. Mark Robinson and Julian Hofmann discuss the company and also touch on what's going well for med-tech business Uniphar (UPR).Last but not least, Jemma Slingo unpacks our latest Big Read on banks. It hasn't been a huge season for guidance upgrades, but there are still positives for the year. Listen to find out more.Timestamps1:29 Rolls Royce10:37 Smith & Nephew19:15 BanksClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

We begin with Mony Group (MONY), better known as Money Supermarket, whose results showed the insurance industry isn't struggling as some fear. Mark Robinson shares all investors need to know. Arthur Sants, our US correspondent and author of this week's Big Read on Nvidia (NVDA), explains the key points from the article. From the threat of DeepSeek and Chinese sanctions to potential positives for the future.Last up, Alex Hamer unpacks the latest on engineer and consultant Wood Group (WG). The company's CFO has stepped down after claiming he was more qualified than he was. Alex and Dan discuss the backdrop and where the valuation now stands.Timestamps1:08 Mony Group9:49 Nvidia23:54 Wood GroupClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Founded in 2010 by Carson Block, Muddy Waters Research is best known for its short-selling, predominantly in the mid-cap space. In this episode of IC Interviews, Block joins Dave Baxter to discuss what it would take for him to bet against the Magnificent Seven, the UK activist investing landscape, opportunities in Vietnam and India, and why China is uninvestable. This episode was recorded on 5 February. Timestamps 00:31 State of short selling9:04 What could change the market 16:30 Going against the Magnificent 718:16 Opportunities in UK sectors 21:28 Saba Capital23:18 Vietnam fund27:15 China30:48 India33:03 How short and long differClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Christoper Akers kicks off the podcast with engineer Renishaw's (RSW) results. From supply chain issues to long-standing murmurs of a sale, find out why investors were disappointed.Valeria Martinez then unpacks designer and manufacturer Filtronic (FTC), whose results were warmly received by the market. Listen to find out how the firm landed contracts with SpaceX, which has been a leading factor in its 300 per cent share price increase over the past year, and how it is expanding to grow its customer base. Last up, we cover British American Tobacco (BAT). Its latest results were not as strong as hoped, thanks to a struggling tobacco alternatives market and strong competition from Philip Morris (PM). Mark Robinson explains all investors need to know.This episode was recorded on 13 February. Timestamps1:30 Renishaw9:24 Filtronic 25:06 British American Tobacco Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

This month, Lord Lee and Alex are joined by Member of Youth Parliament, Cameron Holt. At just 16 years old, Cameron's goal is to get the government to recognise it is failing children with financial literacy. He believes, that through incorporating it into the curriculum, children will increase their confidence in a post-education world, and be more wary of the dangers of online fraud and debt. In the episode, the trio unpack the issues facing children and young people. From ways schools, parents and grandparents can increase young people's interest in finances, to a petition Cameron has started which he hopes will make financial education statutory in secondary schools across the UK.The podcast rounds up with an update from Lord Lee's portfolio, including news on holdings Town Centre Securities (TOWN), Concurrent Technologies (CNC) and PZ Cussons (PZC), plus his take on how Donald Trump will affect the UK. Click here to sign Cameron's petition to make financial lessons statutory in schools. If you have any questions you want to pose to Lord Lee and Alex, write to alex.newman@ft.comRead Cameron's article for the Investors' Chronicle hereTimestamps1:16 Cameron Holt 5:04 What needs to change with financial education 6:03 Lord Lee's experience of learning about finance 9:59 Cameron's study12:55 NatWest shares14:24 Do schools offer financial advice on university 16:14 How to bridge the gap in financial literacy among children 21:35 Cameron's petition 24:51 Updates on Lord Lee's portfolio 27:45 Town Centre Securities29:42 Supermarket Income Reit30:41 Concurrent Technologies31:47 PZ CussonsClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Julian Hofmann opens today's podcast by unpacking results from AstraZeneca (AZN) and GSK (GSK). AstraZeneca had a particularly strong quarter despite China's investigation into the importation of cancer drug, Imjudo. GSK's dividends were up, positive news for income investors, but its vaccine rates have slowed as they are more exposed to the US administration. Julian shares all investors need to know.It's then on to housebuilder Crest Nicholson (CRST). There is growing concern around its £144mn loss, but Natasha Voase lays out whether the worry is justified.Lastly, catering company Compass Group (CPG) released a trading update which showed strong organic growth. Mark Robinson explores the structural drivers behind this, its M&A strategy and its prospects. Timestamps01:52 AstraZeneca15:49 Crest Nicholson27:41 Compass GroupClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

In the latest episode of the IC Interviews, Dave Baxter sits down with Sam Gleave of Liontrust's European Dynamic. The fund seeks out companies lowly valued by investors, but that could generate more cash than they need to sustain strong growth. In the episode, Dave and Sam discuss why the fund is still bullish on European markets, the outlook for banks on the continent, plus how the fund views Hermes (RMS), Novo Nordisk (NOVO.B) and ASML (ASML). The pair also unpack what impact Trump's swathe of tariffs will have on the fund and European companies at wide. This episode was recorded on 24 January.Timestamps 0:33 2025 outlook 2:57 China plays4:15 Industrials4:52 Luxury7:07 M&A 8:48 Banks12:49 Novo Nordisk (NOVO.B)16:47 ASML (ASML) 18:19 Trump, tariffs and the fund20:13 Publicis (PUB)22:02 Sectors Liontrust are wary of23:24 Is the opportunity set growingClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Our panel kick off the podcast with a rundown of the latest news from the AI world. Chinese-owned DeepSeek's smarter and more sustainable design helped knock half a billion dollars from Nvidia's (NVIDIA) market cap. The panel discuss what comes next for AI stocks and return-hungry investors. It's then on to Michael Fahy to chat about this week's main feature on Tesco (TSCO). Michael explores how the supermarket's position has changed over the past few years, the mistakes it has made along the way and what comes next. Last up Val Cipriani and Julian Hoffman discuss AJ Bell's (AJB) recent trading update. Listen to find out how the Budget has impacted the investing platform and how investors should consider the stock moving forward.Timestamps 1:17 DeepSeek13:01 Tesco28:04 AJ BellClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

On the week Donald Trump retook the position of US president, a handful of banking stocks released strong results. Jemma Slingo joins host Dan Jones to explore what investors need to know about Trump's potential impact, the differences between UK and US banks, and a broader outlook for the year. It's then onto this week's cover feature on creating five-year outlooks for markets. Alex Newman runs through his thinking behind the piece, the challenges that arise when predicting market moves, and his predictions for gold.Last up, Julian Hoffman talks weight-loss drugs. He and Dan discuss what investors can expect in the year ahead, why Novo Nordisk's results were disappointing, and more. Timestamps 1:11 US banks12:22 A five-year outlook24:58 BiotechClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Dave Baxter and Dan Jones sit down with the founder of Saba Capital, Boaz Weinstein. Last month, Saba sent the investment trust space into disarray by announcing it wanted to unseat board members at seven underperforming trusts, and merge them or offer shareholders a way out.In the episode, Dave and Dan grill Boaz on how Saba's plans would work, what happens if it doesn't win the votes, his belief that investors will benefit and more.The deadlines for shareholders to vote on Saba's proposals vary, but in many cases, they are due before the end of January: check with your platform for details.How to vote in Saba's big investment trust battleTimestamps 1:45 Are we too preoccupied with discounts?5:04 Critiques of Saba6:53 The plan when the results are in10:05 Professional investors' view 12:21 If they don't win the votes15:01 Cash exits for trusts 16:53 Trusts' unlisted holdings eg. SpaceX19:57 The strategy for a new super-entity23:31 Where Saba's attention will turn next25:55 If they win the vote, will they mimic US processes?28:10 Can Saba keep discounts in check?Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

This week's episode starts off with a discussion of Games Workshop's (GAW) results which showed strong core revenues. Valeria Martinez looks at how the business is performing geographically, the catalysts of its growth, its forecasts and more. Julian Hofmann then gives listeners an insight into our latest cover feature on dividend minnows. He shares the background of his research on the history of dividends in the FTSE 100 and highlights what investors should be wary of when it comes to large-cap dividends. He also touches on some examples from the piece such as brickmaker, Brickabilty (BRCK). Last up is the pig and cattle genetics company Genus (GNS). Shares were up 20 per cent in just one day earlier in the week, a change of tune from its performance in previous years. Julian touches on the backdrop for the company's performance and why it's hard to price. Timestamps1:09 Games Workshop 17:00 Income minnows 25:34 GenusClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

The duo reunite after the festive period for a conversation on how Lord Lee's portfolio performed, why he feels optimistic about the next 12 months and how he's invested a strong flow of dividends.The pair discuss Christie Group plc, a stock Lord Lee suggests is “severely underrated”, his opinion on what to do with a company that's down 50 per cent, and British big-names ITV, Aviva and Supermarket Income Reit.The episode rounds up in the typical style, updating listeners on new holdings or recent exits in Lord Lee's portfolio. If you have any questions you would like answered in the podcast, please send them to alex.newman@ft.comClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.Timestamps 1:14 Optimism about the year ahead3:48 2024 review5:20 Reinvesting dividends6:55 Christie Group plc 10:54 What he would do at a 50 per cent loss 13:41 Should companies consult investors 15:38 Aviva and Direct Line19:39 ITV21:30 Supermarket Income Reit27:18 New positions and recent exits Hosted on Acast. See acast.com/privacy for more information.

We begin with trading updates from retailers and update investors on all they need to know about Next (NXT), M&S (MKS) and Greggs (GRG). There is considerable pressure across the board due to higher national insurance contributions, rising wages and uncertain consumer sentiment. Michael Fahy, Mark Robinson and Alex Newman weigh in.Mark Robinson talks all things risk management, the topic of our latest Big Read. Mark touches on the golden rules to follow, how to protect a portfolio and more.Next up is bond yields, a hot topic given the market turmoil, and the team discuss what's happening and whether bonds can still be considered a diversifier away from stocks.Timestamps1:21 Retailers18:02 Risk managementClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

We begin the year's final podcast discussing activist investor Saba Capital. Funds editor Dave Baxter explores the impact of its demand to remove the boards of seven investment trusts and what investors should do if the changes go ahead.It's then onto Hollywood Bowl's (BOWL) results. The company reported a 7 per cent rise in revenue, but shares still fell 10 per cent. Michael Fahy explains what caused the fall as well as the business's valuation.Last up, our US-based writer Arthur Sants joins in the studio. From the recent market sell-off after comments from the Fed to the Magnificent Seven stocks, investors can find out what to expect from American markets in the coming year. Timestamps 1:17 Saba Capital9:31 Hollywood Bowl17:43 The USClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

After a busy year of geopolitical changes, there is a lot of ground to cover when discussing markets. In this episode, Simon and Dan Jones unpack everything from the mass number of moves to the US market to knotty Aim shares, and the sectors investors should keep an eye on in 2025.Timestamps01:02 2025 prospects06:06 Economic backdrop 10:23 Upgrades and downgrades 15:31 Donald Trump's presidency 21:12 His take on moves to US markets24:16 Buybacks29:20 Aim32:16 IPOs and M&A33:59 Interesting sectors Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Chris Akers unpacks the latest from equipment rental company Ashtead (AHT). The figures slightly underwhelmed the market, but the biggest factor affecting the business was the announcement that it's moving its listing to the US.Onto our latest cover feature on behavioural psychology and investing. Alex Newman lays out his intention with the piece, as well as the importance of recognising what impact our biases have on our investment decisions.It's then on to the plastics business Victrex (VCT) which saw its shares shoot up recently. Julian Hofmann looks at the causes of this and Alex returns to touch on the bid for Aim-traded fintech firm Equals (EQLS).Timestamps01:17 Ashtead09:05 Developmental psychology19:56 Victrex27:21 EqualsClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

As stock pickers, the managers of The Brunner Investment Trust are looking for what they believe are great companies which can grow and deliver returns to shareholders. Whilst this may sound obvious, just what exactly are the common factors in the DNA of a “great” company? Joe Lynam quizzes portfolio manager Julian Bishop on how he and his team go about assessing companies.For more in-depth discussions and insights, visit our website for additional podcast episodes, articles and videos: https://www.brunner.co.uk/en-gb/videos-podcasts-and-reading This content was paid for and produced by The Brunner Investment Trust Hosted on Acast. See acast.com/privacy for more information.

Alex and Lord Lee sit down with the CEO of one of the holdings in Lord Lee's portfolio: James Gundy of the shipping service company, Braemar (BMS).James has been group CEO since 2021 and he unpacks the ins and outs of running a shipbroker on London's main market, how it compares to its competitors and its navigation of some complicated geopolitical waters.As always, the episode closes with an update on Lord Lee's portfolio changes, including why he's buying a new real estate investment trust and why he's focusing on the changes to capital gains tax.Timestamps00:59 What the company does04:23 Lead indicators07:24 Compared to Clarksons 08:57 How Lord Lee got involved12:51 Pricing intangibles16:43 Why shipbroking is dominated by UK-based companies18:20 Why Lord Lee thought it was a good investment19:55 Is volatility good for business?20:59 The sale to Russian oil producer Lukoil27:16 Is Braemar under investigation? 29:39 Financials31:58 Dividends35:10 Lord Lee's portfolio 38:00 Takeovers Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £1 Hosted on Acast. See acast.com/privacy for more information.

We begin with airlines Jet2 (JET2) and EasyJet (EZJ) who recently released results. Michael Fahy explores the current demand for travel and package holidays, and the reputational issues affecting share valuations. The future of the North Sea is murky but the industry now has clarity on its taxes. Our commodities expert, Alex Hamer, lays out the opportunities, challenges and changing operating costs in the sector.AJ Bell (AJB) recently changed how its users can vote at AGMs for the companies they own – offering a digital option, in the same way Interactive Investors users have been able to since 2021. Holly McKechnie unpacks why this is an important move and the impact it may have.Timestamps1:23 Airline stocks12:34 The North Sea27:04 Shareholder democracyClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

In the latest episode of the IC Interviews, Val Cipriani, personal finance editor, sits down with Stefan Gries of BlackRock Greater Europe Trust. The fund is known for focusing on businesses with dependable profits and finds success even though it takes less risk than the average investor.Hear Gries's take on Dutch semiconductor stock ASML (AMS), and how the industry will fare in light of Donald Trump's win. The duo also cover the prospects of the Chinese and UK markets, the fund's stock-picking methods which European sectors are ripe for investor attention.Timestamps 0:49 What the fund does2:34 Changes to the strategy6:02 Outlook on the market 8:53 US election result 11:06 Bullish versus Bearish13:46 Stockpicking17:13 Novo Nordisk 21:46 ASML 25:25 Semiconductors in the wake of Trump's win32:57 China and post-Covid recovery 35:55 UK market38:19 Granola stocks40:39 Wider European stocks 42:42 Promising sectors Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

We begin with software company Sage (SGE). Shares are up and the team unpacks the drivers of this rise and explores whether investors should be concerned about competition in the industry. Illinois Tool Works (US:ITW) next. It's larger than all but five stocks included in the FTSE 100 but remains relatively unknown on this side of the pond. Our team explore what the company does and the metrics that lead it to feature on our annual US quality screen.Last up, it's property company Grainger (GRI). Demand has been strong this year but its share price has been relatively flat. We look at why this is the case and how the valuation appears.Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

British-based luxury fashion brand Burberry (BRBY) has had a hard time of late. Our team delve into what's gone wrong over and question whether the low valuation is attractive enough for investors to take a gamble.It's then onto our Investment Trust Special. We explore what trusts are most vulnerable to consolidation and some that could be fruitful in the changing macroeconomic environment.Last up, it's specialist British chemical company Croda (CRDA). The latest update shows signs of life but two profit warnings over the past 18 months could hold back its growth. Julian Hofmann looks into the details. Timestamps 1:31 Burberry 15:38 Investment trusts27:48 Croda Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £1 Hosted on Acast. See acast.com/privacy for more information.

Lord Lee and Alex reunite just a day after the US election result and a week on from the Autumn Budget. In the episode, the pair unpack how the latter will affect UK private investors and the economy at large, and Lord Lee gives his opinion on the effectiveness of the changes announced by chancellor Rachel Reeves.Also, listen to find out the changes to Lord Lee's portfolio and his take on Trump's presidential win. Timestamps 1:18 Why the Budget is pleasing for private investors3:42 Lord Lee's view of Labour's tone 7:19 Nichols and FW Thorpe sales10:03 Will Budget changes mean a change in tactic?11:14 Inheritance tax 13:05 Niche markets15:40 Impact on family businesses property relief and farms18:32 What should Labour aim for 21:25 How Lord Lee's portfolio has been recently 25:14 Trump's reelection Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £1 Hosted on Acast. See acast.com/privacy for more information.

Auto Trader's (AUTO) recent results were not well received. A slowdown in vehicle production and its position within a tight market is squeezing growth prospects. Our experts dive into what it means for investors. It's then on to the impact of the Budget. The panel unpacks what sectors will be most affected by the changes, and the potential cost-saving measures companies can take to mitigate rising NI contributions.Last up, bond yields. Both the Budget and the US election will alter the fiscal outlook and our team look at who the winners and losers will be. Dan Jones is joined by Mark Robinson, Alex Newman, Julian Hofmann and Hermione Taylor.Editing by Madi ApthorpeTimestamps1:23 Auto Trader13:25 The Budget21:03 BondsClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Returning a second time in the IC Interviews hot seat, Terry Smith is one of the biggest names in the investing world. Having set up the eponymous Fundsmith in 2010, he now manages more than £22bn of British savers' money and has had his fair share of celebration and criticism.Funds editor Dave Baxter and Smith unpack everything from Magnificent Seven stocks and the effect of weight-loss drugs on stock markets, to consumer staples and the reason Smith doesn't want to own market favourite, Nvidia.Also, find out what quality Smith looks for in companies and fund managers, plus why the fund's allocation to UK stocks is so minimal. Timestamps00:38 Magnificent Seven stocks3:52 Nvidia 6:41 AI08:57 Consumer staples and weight-loss drugs12:06 Novo Nordisk17:36 What he looks for in companies 20:23 Nike 22:07 Asset allocation and share buybacks24:48 UK companies and Asia 29:19 Financials 30:27 Judging when there's a crisis versus a mispricing 35:09 Criticisms of the buy and sell process39:44 Atlas Copco 41:44 Next and Autotrader Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

The Autumn Budget brought a swathe of changes to the way investors can harness the most of the market. From capital gains changes to pensions, our team unpack what investors need to know.Find out everything you need to know about the BudgetHSBC (HSBC) recently announced a reorganisation that will affect shareholders. The panel of experts report on what the business is set to achieve, and the outlook for interest income as base rates fall.Last up, the team delve into what led to the small share rally for YouGov (YOU) after its latest trading update.Timestamps 1:54 Budget17:30 HSBC26:16 YouGov Hosted on Acast. See acast.com/privacy for more information.

Mark Robinson starts the show by unpacking Morgan Sindall's (MGNS) significant trading update, looking at the drivers behind the share price rise and the scope for the company to increase its market share.It's then on to our Aim 100 special. Michael Fahy and Alex Newman share their take on the leading brick supplier Brickability (BRCK) and technology distributor Midwich (MIDW), discussing what each sector looks like at the moment and what should investors be aware of.Timestamps1:14 Morgan Sindall9:58 Brickability 23:04 MidiwchClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

We begin with National Grid's (NG) transformation plans. Jemma Slingo and Alex Newman weigh in on whether it should now be considered a growth rather than income stock, its US business and more.It's then onto car dealership Vertu (VTU). Mark Robinson runs through the driving factors behind Vertu's performance, the business' valuation and its prospects in a struggling market.Last up, Holly McKechnie dives into the knotty issue of investment trust costs. In September HM Treasury announced it was replacing a regime in place since Britain's time in the EU, and angst has since swelled. Find out what the Isa and pension providers are saying and what the change actually means.Timestamps 1:46 National Grid14:52 Vertu26:06 Investment trust costsClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

In this episode of IC Interviews, Paul ffolkes Davis and funds editor Dave Baxter discuss the Japanese small and mid-cap specialist fund, which has proven to be quite fruitful for investors.Find out why ffolkes Davis believes in the yen's strength plus his thoughts on Japan's macro trends, the big investment trust risers and fallers this year and more.Timestamps 00:56 Japan and Yen strength 4:49 Macro themes in Japan7:40 Valuations11:48 Activism 18:10 Private versus public 20:39 Corporate reform23:55 Is there a cap for the trust26:51 Recent activity in the portfolio31:09 7/11 bid Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

Associate editor James Norrington starts the show, covering this week's Big Read. He and Dan unpack inflationary vs deflationary forces in Western economies and what it means for stock picking and building portfolios. Madelaine Apthorpe is then in the hot seat instead of behind the soundboard to discuss her investigation into cocoa inflation and the confectionery industry. She touches on the reasons for the price rises, the outcome for consumers and what it means for the industry. Last up, Julian Hoffman and Mark Robinson unpack Boeing's latest results and the strike action the company is facing. They discuss the knock-on effects for other companies and how the new CEO is trying to improve safety.Timestamps00:58 Debt, demographics and money16:26 Cocoa23:38 BoeingClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only. Hosted on Acast. See acast.com/privacy for more information.

This month, Alex and Lord Lee are joined by the CEO of Ampario, Richard Edwards. Ampario is an Aim-traded natural feed additives group, a niche business but one that exports its products to over 80 countries and has been held by Lord Lee for 14 years.In the episode, the trio discuss the ins and outs of running an Aim company, why Lord Lee believes the business is well-placed in today's markets, its sustainable practices and more. Hosted on Acast. See acast.com/privacy for more information.

This week's episode begins with a property leaser to the healthcare sector, Life Science Reit (LABS). Property writer Natasha runs through the results, where the chief exec is focusing and whether a takeover is on the cards.It's then onto our latest Big Read on investing for your children. From the best accounts to use, the top funds to pick, and educating your children about investing, Val Cipriani runs through everything parents need to know.Lastly, Julian Hofmann joins to unpack China's stimulus measures. What impact will it have on the stock market? And what funds can investors use to get involved in the action?Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you're not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.Timestamps 00:56 Reits11:02 Investing for your children21:00 China's stimulusRead the stories mentioned in the showLife Science Reit trades on steep discount to NAVChina's bounce may be short-livedThe best ways to invest for your children Hosted on Acast. See acast.com/privacy for more information.